Key result
Pre-operative diagnosis of silent coronary ischaemia using CTA-FFR CT reduced one-year cardiovascular death (0.7% vs 5.9%, p=0.036) and MI (2.2% vs 8.1%, p=0.028) compared with standard care.
Why the study?
Patients undergoing peripheral vascular surgery have an increased risk of death and MI that may stem from unsuspected silent coronary ischaemia, but whether pre-operative diagnosis via FFR CT can reduce these events was unknown.
Does pre-operative coronary CTA-FFR CT testing reduce cardiovascular death and MI in asymptomatic patients undergoing lower extremity surgical revascularisation?
Cohort (n=270)
No
Does pre-operative coronary CTA-FFR CT testing reduce cardiovascular death and MI in asymptomatic patients undergoing lower extremity surgical revascularisation?
Absolute Event Rate: 0.7% vs 5.9%
p-value: p=0.036
Pre-operative coronary CTA-FFR CT testing in asymptomatic patients undergoing lower extremity revascularisation facilitates targeted post-operative coronary revascularisation, significantly reducing 1-year CV death and MI.
Supports pre-operative CTA-FFR CT in vascular surgery patients; hypothesis-generating pending randomized confirmation.
Objective Patients undergoing peripheral vascular surgery have increased risk of death and myocardial infarction (MI), which may be due to unsuspected (silent) coronary ischaemia. The aim was to determine whether pre-operative diagnosis of silent ischaemia using coronary computed tomography (CT) derived fractional flow reserve (FFR CT ) can facilitate multidisciplinary care to reduce post-operative death and MI, and improve survival. Methods This was a single centre prospective study with historic controls. Patients with no cardiac symptoms undergoing lower extremity surgical revascularisation with pre-operative coronary CTA-FFR CT testing were compared with historic controls with standard pre-operative testing. Silent coronary ischaemia was defined as FFR CT ≤ 0.80 distal to coronary stenosis with FFR CT ≤ 0.75 indicating severe ischaemia. End points included cardiovascular (CV) death, MI, and all cause death through one year follow up. Results There were no statistically significant differences between CT angiography (CTA-FFR CT) ( n = 135) and control ( n = 135) patients with regard to age (66 ± 8 years), sex, comorbidities, or surgery performed. Coronary CTA showed ≥ 50% stenosis in 70% of patients with left main stenosis in 7%. FFR CT revealed silent coronary ischaemia in 68% of patients with severe ischaemia in 53%. The status of coronary ischaemia was unknown in the controls. At 30 days, CV death and MI in the CTA-FFR CT group were not statistically significantly different from controls (0% vs . 3.7% [ p = .060] and 0.7% vs. 5.2% [ p = .066], respectively). Post-operative coronary revascularisation was performed in 54 patients to relieve silent ischaemia (percutaneous coronary intervention in 47, coronary artery bypass graft in seven). At one year, CTA-FFR CT patients had fewer CV deaths (0.7% vs. 5.9%; p = .036) and MIs (2.2% vs. 8.1%; p = .028) and improved survival ( p = .018) compared with controls. Conclusion Pre-operative diagnosis of silent coronary ischaemia in patients undergoing lower extremity revascularisation surgery can facilitate multidisciplinary patient care with selective post-operative coronary revascularisation. This strategy reduced post-operative death and MI and improved one year survival compared with standard care.
No takes yet. Share an insight, caveat, or question.
Krieviņš et al. (2020) conducted a cohort in Lower extremity surgical revascularisation (n=270). Pre-operative coronary CTA-FFR CT testing vs. Historic controls with standard pre-operative testing was evaluated on Cardiovascular death at one year (p=0.036). Pre-operative diagnosis of silent coronary ischaemia using CTA-FFR CT reduced one-year cardiovascular death (0.7% vs 5.9%, p=0.036) and MI (2.2% vs 8.1%, p=0.028) compared with standard care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: